Personalized medicine and pay-for-performance: should pharmaceutical firms be fully penalized when treatment fails?
-
1
Universidad de La Rioja
info
Revista:
PharmacoEconomics
ISSN: 1170-7690
Any de publicació: 2018
Tipus: Article